{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:21:44Z","timestamp":1787678504687,"version":"build-2784847793"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014269","name":"Uniwersytet Medyczny w Bia\u0142ymstoku","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005297","name":"Medical University of Bialystok","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005297","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bioorg.2026.110149","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T06:13:49Z","timestamp":1782108829000},"page":"110149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Targeting microtubule dynamics: synthesis and evaluation of novel 4-thiazolidinone derivatives in pancreatic Cancer"],"prefix":"10.1016","volume":"180","author":[{"given":"Rostyslav","family":"Dudchak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serhii","family":"Holota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Podolak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga Klaudia","family":"Szewczyk-Roszczenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ihor","family":"Yushyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazar","family":"Solodyak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olexandr","family":"Karpenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Czarnomysy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Gornowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Borzym-Kluczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yegor","family":"Vassetzky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Bielawska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Bielawski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Lesyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.110149_bb0005","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1053\/j.gastro.2020.10.007","article-title":"Worldwide burden of, risk factors for, and trends in pancreatic Cancer","volume":"160","author":"Huang","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bioorg.2026.110149_bb0010","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70318","article-title":"Global trend in pancreatic Cancer prevalence rates through 2040: an illness-death modeling study","volume":"13","author":"Hesami","year":"2024","journal-title":"Cancer Med."},{"key":"10.1016\/j.bioorg.2026.110149_bb0015","doi-asserted-by":"crossref","first-page":"921","DOI":"10.2165\/00003495-199957060-00007","article-title":"Rosiglitazone","volume":"57","author":"Barman Balfour","year":"1999","journal-title":"Drugs"},{"key":"10.1016\/j.bioorg.2026.110149_bb0020","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2165\/00003495-200060020-00009","article-title":"Pioglitazone","volume":"60","author":"Gillies","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.bioorg.2026.110149_bb0025","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s40265-021-01523-z","article-title":"Ponesimod: first approval","volume":"81","author":"Markham","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.bioorg.2026.110149_bb0030","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1592\/phco.28.5.646","article-title":"Epalrestat: an aldose reductase inhibitor for the treatment of diabetic neuropathy","volume":"28","author":"Ramirez","year":"2008","journal-title":"Pharmacother. J. Hum. Pharmacol. Drug Ther."},{"key":"10.1016\/j.bioorg.2026.110149_bb0035","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1043-6618(09)80059-5","article-title":"Etozoline and vascular spasm","volume":"22","author":"Belluco","year":"1990","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bioorg.2026.110149_bb0040","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3109\/1547691X.2014.978055","article-title":"PPAR \u03b3 -dependent anti-tumor and immunomodulatory actions of pioglitazone","volume":"12","author":"El-Sisi","year":"2015","journal-title":"J. Immunotoxicol."},{"key":"10.1016\/j.bioorg.2026.110149_bb0045","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1158\/1535-7163.MCT-05-0347","article-title":"Rosiglitazone suppresses human lung carcinoma cell growth through PPAR\u03b3-dependent and PPAR\u03b3-independent signal pathways","volume":"5","author":"Han","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bioorg.2026.110149_bb0050","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1002\/jcp.26225","article-title":"Pioglitazone inhibits Cancer cell growth through STAT3 inhibition and enhanced AIF expression via a PPAR\u03b3-independent pathway","volume":"233","author":"Tsubaki","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bioorg.2026.110149_bb0055","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.pharep.2015.08.001","article-title":"Pioglitazone, an anti-diabetic drug requires sustained MAPK activation for its anti-tumor activity in MCF7 breast cancer cells, independent of PPAR-\u03b3 pathway","volume":"68","author":"Kole","year":"2016","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.bioorg.2026.110149_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232113135","article-title":"4-Thiazolidinone-bearing hybrid molecules in anticancer drug design","volume":"23","author":"Roszczenko","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110149_bb0065","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2174\/1385272825999210101234704","article-title":"An insight into synthesis and anticancer potential of thiazole and 4-Thiazolidinone containing motifs","volume":"25","author":"Bhagat","year":"2021","journal-title":"Curr. Org. Chem."},{"key":"10.1016\/j.bioorg.2026.110149_bb0070","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.2174\/1871520621666210706104227","article-title":"The role of 4-Thiazolidinone scaffold in targeting variable biomarkers and pathways involving Cancer","volume":"22","author":"Negi","year":"2022","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110149_bb0075","doi-asserted-by":"crossref","first-page":"5185","DOI":"10.1007\/s11030-024-11093-3","article-title":"Thiazolidinedione derivatives: emerging role in Cancer therapy","volume":"29","author":"Latambale","year":"2025","journal-title":"Mol. Divers."},{"key":"10.1016\/j.bioorg.2026.110149_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202200419","article-title":"Anticancer 5-arylidene-2-(4-hydroxyphenyl)aminothiazol-4(5H)-ones as tubulin inhibitors","volume":"355","author":"Rehulka","year":"2022","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.bioorg.2026.110149_bb0085","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.mehy.2006.06.054","article-title":"Thiazolidinedione anti-Cancer activity: is inhibition of microtubule assembly implicated?","volume":"68","author":"Russu","year":"2007","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.bioorg.2026.110149_bb0090","doi-asserted-by":"crossref","first-page":"230","DOI":"10.2174\/1871520615666160504093904","article-title":"Thiazolidinone constraint combretastatin Analogs as novel antitubulin agents: design, synthesis, biological evaluation and docking studies","volume":"17","author":"Sharma","year":"2017","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110149_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103188","article-title":"Discovery of certain benzyl\/phenethyl thiazolidinone-indole hybrids as potential anti-proliferative agents: synthesis, molecular modeling and tubulin polymerization inhibition study","volume":"92","author":"Sigalapalli","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110149_bb0100","doi-asserted-by":"crossref","DOI":"10.1039\/D2MD00442A","article-title":"Design, synthesis and in vitro cytotoxicity evaluation of indolo-pyrazoles grafted with thiazolidinone as tubulin polymerization inhibitors","author":"Soni","year":"2023","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110149_bb0105","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1254\/jphs.13064FP","article-title":"Antitumor activity of (2E,5Z)-5-(2-hydroxybenzylidene)-2-((4-phenoxyphenyl)Imino) thiazolidin-4-one, a novel microtubule-depolymerizing agent, in U87MG human glioblastoma cells and corresponding mouse xenograft model","volume":"122","author":"Zhang","year":"2013","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.bioorg.2026.110149_bb0110","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.18632\/oncotarget.2946","article-title":"\u03b2III-tubulin: a novel mediator of chemoresistance and metastases in pancreatic Cancer","volume":"6","author":"McCarroll","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bioorg.2026.110149_bb0115","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1593\/neo.05304","article-title":"Vascular targeting in pancreatic Cancer: the novel tubulin-binding agent ZD6126 reveals antitumor activity in primary and metastatic tumor models","volume":"7","author":"Kleespies","year":"2005","journal-title":"Neoplasia"},{"key":"10.1016\/j.bioorg.2026.110149_bb0120","doi-asserted-by":"crossref","first-page":"13121","DOI":"10.1007\/s13277-016-5160-5","article-title":"A novel colchicine-based microtubule inhibitor exhibits potent antitumor activity by inducing mitochondrial mediated apoptosis in MIA PaCa-2 pancreatic Cancer cells","volume":"37","author":"Kumar","year":"2016","journal-title":"Tumour Biol."},{"key":"10.1016\/j.bioorg.2026.110149_bb0125","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13046-018-1009-7","article-title":"Therapeutic efficacy of a novel \u03b2III\/\u03b2IV-tubulin inhibitor (VERU-111) in pancreatic Cancer","volume":"38","author":"Kashyap","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bioorg.2026.110149_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118238","article-title":"Tubulin- and ROS-dependent antiproliferative mechanism of a potent analogue of noscapine, N-Propargyl noscapine","volume":"378","author":"Nambiar","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.bioorg.2026.110149_bb0135","doi-asserted-by":"crossref","first-page":"19905","DOI":"10.1021\/acs.jmedchem.4c02419","article-title":"Palladium-mediated bioorthogonal system for prodrug activation of N -benzylbenzamide-containing tubulin polymerization inhibitors for the treatment of solid tumors","volume":"67","author":"Li","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110149_bb0140","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1021\/cb300641h","article-title":"Glaziovianin a prevents endosome maturation via inhibiting microtubule dynamics","volume":"8","author":"Chinen","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bioorg.2026.110149_bb0145","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1021\/acsmedchemlett.9b00526","article-title":"Structure optimization of Gatastatin for the development of \u03b3-tubulin-specific inhibitor","volume":"11","author":"Shintani","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110149_bb0150","article-title":"Molecules with alkyne fragment in medicinal chemistry: the path from neurotoxins to drugs","volume":"15","author":"Zelisko","year":"2025","journal-title":"Eur. J. Med. Chem. Rep."},{"key":"10.1016\/j.bioorg.2026.110149_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106982","article-title":"Click chemistry in the synthesis of antibody-drug conjugates","volume":"143","author":"Dudchak","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110149_bb0160","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ejmech.2018.04.011","article-title":"Recent advances in trimethoxyphenyl (TMP) based tubulin inhibitors targeting the colchicine binding site","volume":"151","author":"Li","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110149_bb0165","doi-asserted-by":"crossref","first-page":"39728","DOI":"10.1039\/D1RA07922K","article-title":"Design, synthesis, docking study and anticancer evaluation of new trimethoxyphenyl pyridine derivatives as tubulin inhibitors and apoptosis inducers","volume":"11","author":"Hagras","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2026.110149_bb0170","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1007\/s00044-023-03153-4","article-title":"The trimethoxyphenyl (TMP) functional group: a versatile pharmacophore","volume":"32","author":"Langarizadeh","year":"2023","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2026.110149_bb0175","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.2174\/1871520618666180718104647","article-title":"One-pot synthesis of triazolo-heterolignans: biological evaluation and molecular docking studies as tubulin inhibitors","volume":"18","author":"Reddy","year":"2019","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110149_bb0180","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1039\/C9MD00458K","article-title":"Application of triazoles as bioisosteres and linkers in the development of microtubule targeting agents","volume":"11","author":"Malik","year":"2020","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110149_bb0185","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ejmech.2017.09.063","article-title":"Synthesis, antiproliferative, anti-tubulin activity, and docking study of new 1,2,4-triazoles as potential combretastatin analogues","volume":"141","author":"Mustafa","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110149_bb0190","doi-asserted-by":"crossref","DOI":"10.3390\/cells14120861","article-title":"5-Ene-2-arylaminothiazol-4(5H)-ones induce apoptosis in breast cancer cells","volume":"14","author":"Dudchak","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.bioorg.2026.110149_bb0195","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.ejmech.2006.12.006","article-title":"New 5-substituted Thiazolo[3,2-b][1,2,4]Triazol-6-ones: synthesis and anticancer evaluation","volume":"42","author":"Lesyk","year":"2007","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110149_bb0200","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.3390\/molecules26041162","article-title":"Synthesis, characterization and in vitro evaluation of novel 5-Ene-Thiazolo[3,2-b][1,2,4]Triazole-6(5H)-ones as possible anticancer agents","volume":"26","author":"Holota","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110149_bb0205","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1080\/00397911.2017.1309669","article-title":"Facile one-pot synthesis of 5-aryl\/Heterylidene-2-(2-hydroxyethyl- and 3-hydroxypropylamino)-Thiazol-4-ones via catalytic Aminolysis","volume":"47","author":"Golota","year":"2017","journal-title":"Synth. Commun."},{"key":"10.1016\/j.bioorg.2026.110149_bb0210","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead- and drug-like compounds: the rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.bioorg.2026.110149_bb0215","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the Oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110149_bb0220","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/med.10041","article-title":"Selection criteria for drug-like compounds","volume":"23","author":"Muegge","year":"2003","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bioorg.2026.110149_bb0225","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.110149_bb0230","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/cmdc.201600182","article-title":"A BOILED-egg to predict gastrointestinal absorption and brain penetration of small molecules","volume":"11","author":"Daina","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2026.110149_bb0235","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/jnci\/83.11.757","article-title":"Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines","volume":"83","author":"Monks","year":"1991","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"10.1016\/j.bioorg.2026.110149_bb0240","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ddr.430340203","article-title":"Some practical considerations and applications of the National Cancer Institute in vitro anticancer drug discovery screen","volume":"34","author":"Boyd","year":"1995","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.bioorg.2026.110149_bb0245","series-title":"Anticancer Drug Development Guide","first-page":"23","article-title":"The NCI In Vitro Anticancer Drug Discovery Screen","author":"Boyd","year":"1997"},{"key":"10.1016\/j.bioorg.2026.110149_bb0250","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nrc1951","article-title":"The NCI60 human tumour cell line anticancer drug screen","volume":"6","author":"Shoemaker","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioorg.2026.110149_bb0255","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1038\/nprot.2006.339","article-title":"Clonogenic assay of cells in vitro","volume":"1","author":"Franken","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bioorg.2026.110149_bb0260","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejmech.2014.09.051","article-title":"Recent developments in tubulin polymerization inhibitors: an overview","volume":"87","author":"Kaur","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110149_bb0265","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/0092-8674(81)90072-6","article-title":"Unpolymerized tubulin modulates the level of tubulin mRNAs","volume":"25","author":"Cleveland","year":"1981","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2026.110149_bb0270","doi-asserted-by":"crossref","first-page":"5870","DOI":"10.1158\/0008-5472.CAN-09-4281","article-title":"Microtubule-disrupting chemotherapeutics result in enhanced proteasome-mediated degradation and disappearance of tubulin in neural cells","volume":"70","author":"Huff","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2026.110149_bb0275","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202000342","article-title":"5-Arylidene-2-(4-hydroxyphenyl)Aminothiazol-4(5 H)-ones with selective inhibitory activity against some leukemia cell lines","volume":"354","author":"Subtelna","year":"2021","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.bioorg.2026.110149_bb0280","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.chempr.2016.12.005","article-title":"Structural basis of cis- and trans-combretastatin binding to tubulin","volume":"2","author":"Gaspari","year":"2017","journal-title":"Chem"},{"key":"10.1016\/j.bioorg.2026.110149_bb0285","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nature02393","article-title":"Insight into tubulin regulation from a complex with colchicine and a Stathmin-like domain","volume":"428","author":"Ravelli","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2026.110149_bb0290","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jmb.2017.01.001","article-title":"Insights into the distinct mechanisms of action of taxane and non-taxane microtubule stabilizers from cryo-EM structures","volume":"429","author":"Kellogg","year":"2017","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bioorg.2026.110149_bb0295","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1517\/17460441.2.4.469","article-title":"Ligand efficiency indices for effective drug discovery","volume":"2","author":"Abad-Zapatero","year":"2007","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.bioorg.2026.110149_bb0300","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.bioorg.2026.110149_bb0305","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nprot.2007.30","article-title":"In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro","volume":"2","author":"Liang","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bioorg.2026.110149_bb0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cyto.990080101","article-title":"A pragmatic approach to the analysis of DNA histograms with a definable G1 peak","volume":"8","author":"Watson","year":"1987","journal-title":"Cytometry"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826006851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826006851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T16:51:38Z","timestamp":1787676698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826006851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":62,"alternative-id":["S0045206826006851"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110149","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting microtubule dynamics: synthesis and evaluation of novel 4-thiazolidinone derivatives in pancreatic Cancer","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110149","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110149"}}